Live Terminal
Telegram

Sahajanand Medical Technologies shares debut at 8% premium on NSE — should you buy, sell or hold?

Share on WhatsApp Telegram
⚡ Instant Key Takeaways (TL;DR)
🎯
Core Development: Sahajanand Medical Technologies shares debut at 8% premium on NSE — should you buy, sell or hold?
📊
Market & Financial Impact: Shares of Sahajanand Medical Technologies made a positive debut on the stock exchanges on October 23, listing at a premium of nearly 8% over the company's initial public offering (IPO) price.
💡
Actionable Insight: 🟢 Bullish Trigger: Positive business expansion or earnings beat may attract institutional and retail buying.

Shares of Sahajanand Medical Technologies made a positive debut on the stock exchanges on October 23, listing at a premium of nearly 8 percent over the company's initial public offering (IPO) price.

The shares listed at Rs 371.15 on the National Stock Exchange (NSE), marking a premium of 7.89 percent over the issue price of Rs 344 per share. On the BSE, the stock debuted at Rs 368.05, up 6.99 percent from the IPO price.

Following the listing, Sahajanand Medical Technologies' market capitalisation stood at around Rs 3,741.11 crore.

The listing was stronger than grey market expectations. The shares were commanding a grey market premium (GMP), indicating an estimated listing gain of around 5 percent on the morning of October 23, according to Investorgain.

Read Also: Tonbo Imaging shares list at 66% premium on BSE, NSE — should you buy, sell or hold?

📰
Official Publisher Attribution: This report is aggregated from Moneycontrol. ZeroLive provides live aggregation, automated sentiment synthesis, and exchange disclosure monitoring for retail market participants.
Read Original Full Coverage on Moneycontrol ↗
⚡
Get Breaking Stock Alerts & Q-Results on Telegram
Real-time 1200x675 image cards and financial filings delivered instantly.
Join @Zerolive_news ↗
Link copied to clipboard! ✅